A new perspective of neuromyopathy to explain intractable pancreatic cancer pains; Dry needling as an effective adjunct to neurolytic blocks

Indian Journal of Palliative Care

Volumn 22, Issue 1, 2016, Pages 85-93

  Vas, Lakshmi ^a   Phanse, Sushama ^a   Pai, Renuka ^a  

^a Ashirvad Institute for Pain Management and Research   (India)

Author keywords

Myofascial trigger points; Neuromyopathy; Pancreatic cancer pain; Ultrasound guided dry needling; Viscerosomatic convergence

Indexed keywords

EID: 85000471189     PISSN: 09731075     EISSN: 19983735     Source Type: Journal    
DOI: 10.4103/0973-1075.173957     Document Type: Article

References (48)

1. Christo PJ, Mazloomdoost D. Interventional pain treatments for cancer pain. Ann N Y Acad Sci 2008;1138:299-328.
2. Tay W, Ho KY. The role of interventional therapies in cancer pain management. Ann Acad Med Singapore 2009;38:989-97.
3. Sharfman WH, Walsh TD. Has the analgesic efficacy of neurolytic celiac plexus block been demonstrated in pancreatic cancer pain? Pain 1990;41:267-71.
4. Yan BM, Myers RP. Neurolytic celiac plexus block for pain control in unresectable pancreatic cancer. Am J Gastroenterol 2007;102:430-8.
5. Sikandar S, Dickenson AH. Visceral pain: The ins and outs, the ups and downs. Curr Opin Support Palliat Care 2012;6:17-26.
6. Huggett MT, Pereira SP. Diagnosing and managing pancreatic cancer. Practitioner 2011;255:21-3.
7. Wyse JM, Chen YI, Sahai AV. Celiac plexus neurolysis in the management of unresectable pancreatic cancer: when and how? World J Gastroenterol 2014;20:2186-92.
8. Caraceni A, Portenoy RK. Pain management in patients with pancreatic carcinoma. Cancer 1996;78 3 Suppl:639-53.
9. Ware JE, Kosinski M, Keller SD. How to Score the SF-12 Physical and Mental Health Summary Scales. 2nd ed. Boston: The Health Institute; 1995.
10. Cosman ER Jr., Cosman ER Sr. Electric and thermal field effects in tissue around radiofrequency electrodes. Pain Med 2005;6:405-24.
11. Wang T, Tian FZ, Cai ZH, Li X, Cheng T, Shi L, et al. Ultrasonic interventional analgesia in pancreatic carcinoma with chemical destruction of celiac ganglion. World J Gastroenterol 2006;12:3288-91.
12. Wiechowska-Kozlowska A, Boer K, Wójcicki M, Milkiewicz P. The efficacy and safety of endoscopic ultrasound-guided celiac plexus neurolysis for treatment of pain in patients with pancreatic cancer. Gastroenterol Res Pract 2012;2012:503098.
13. Michaels AJ, Draganov PV. Endoscopic ultrasonography guided celiac plexus neurolysis and celiac plexus block in the management of pain due to pancreatic cancer and chronic pancreatitis. World J Gastroenterol 2007;13:3575-80.
14. Fallon MT. Neuropathic pain in cancer. Br J Anaesth 2013;111:105-11.
15. Chen T, Wai T. Pain management in advanced pancreatic cancer: Local experience in caritas medical centre. HKSPM Newsl 2009;1:24-6.
16. Grundy D. Neuroanatomy of visceral nociception: vagal and splanchnic afferent. Gut 2002;51 Suppl 1:i2-5.
17. Gebhart GF. Visceral pain-peripheral sensitisation. Gut 2000;47 Suppl 4:iv54-5.
18. Sengupta JN. Visceral pain: The neurophysiological mechanism. Handb Exp Pharmacol 2009;194:31-74.
19. Jänig W, Häbler HJ. Physiology and pathophysiology of visceral pain. Schmerz 2002;16:429-46.
20. Agur AM, Dalley AF, editors. Grant's Atlas of Anatomy. 11th ed. Philadelphia: Lippincott, Williams & Wilkins; 2005.
21. Bonica JJ. Autonomic innervation of the viscera in relation to nerve block. Anesthesiology 1968;29:793-813.
22. Regan JM, Peng P. Neurophysiology of cancer pain. Cancer Control 2000;7:111-9.
23. Woolf CJ, King AE. Dynamic alterations in the cutaneous mechanoreceptive fields of dorsal horn neurons in the rat spinal cord. J Neurosci 1990;10:2717-26.
24. Vecchiet L, Vecchiet J, Giamberardino MA. Referred muscle pain: Clinical and pathophysiologic aspects. Curr Rev Pain 1999;3:489-98.
25. Gerwin RD. Myofascial and visceral pain syndromes: Visceral-somatic pain representations. J Musculoskelet Pain 2002;10:165-75.
26. Giamberardino MA. Referred muscle pain/hyperalgesia and central sensitisation. J Rehabil Med 2003;41 Suppl:85-8.
27. Simons DG, Travell JG, Simons LS. Travell and Simons' Myofascial Pain and Dysfunction: The Trigger Point Manual. Upper Half of Body. 2nd ed., Vol. 1. Baltimore, MD: Williams & Wilkins; 1999.
28. Foreman RD. Viscerosomatic convergence onto spinal neurons responding to afferent fibers located in the inferior cardiac nerv. Brain Res 1977;137:164-8.
29. Dommerholt J. Dry needling-Peripheral and central considerations. J Man Manip Ther 2011;19:223-7.
30. Shah JP, Gilliams EA. Uncovering the biochemical milieu of myofascial trigger points using in vivo microdialysis: An application of muscle pain concepts to myofascial pain syndrome. J Bodyw Mov Ther 2008;12:371-84.
31. Kuan TS, Hsieh YL, Chen SM, Chen JT, Yen WC, Hong CZ. The myofascial trigger point region: correlation between the degree of irritability and the prevalence of endplate noise. Am J Phys Med Rehabil 2007;86:183-9.
32. Mense S. The pathogenesis of muscle pain. Curr Pain Headache Rep 2003;7:419-25.
33. Vas L, Pai R, Khandagale N, Pattnaik M. Pulsed radiofrequency of the composite nerve supply to the knee joint as a new technique for relieving osteoarthritic pain: A preliminary report. Pain Physician 2014;17:493-506.
34. Vas L, Khandagale N, Pai R. Successful management of chronic postsurgical pain following total knee replacement. Pain Med 2014;15:1781-5.
35. Vas L, Khandagale N, Pai R. Painful camptocormia as a complication of radiofrequency denervation of lumbar facet joints. Pain Physician 2014;17:E654-7.
36. Vas L, Pai R. Successful reversal of complex regional pain syndrome type 1 of both upper extremities in five patients. Pain Med 2012;13:1253-6.
37. Vas LC, Pai R, Radhakrishnan M. Ultrasound appearance of forearm muscles in 18 patients with complex regional pain syndrome 1 of the upper extremity. Pain Pract 2013;13:76-88.
38. Vas L, Pai R. Reversal of complex regional pain syndrome type 2 and the subsequent management of complex regional pain syndrome type 1 occurring after corrective surgery for residual ulnar claw. Pain Med 2014;15:1059-63.
39. Vas L, Pai R. Musculoskeletal Ultrasonography to distinguish muscle changes in complex regional pain syndrome type 1 from those of neuropathic pain: An observational study. Pain Pract 2015;DOI: 10. 1111/papr. 12338.
40. Vas L, Patnaik M, Walker V, Pai R. Treatment of a patient with interstitial cystitis/painful bladder syndrome as a neuropathic pain condition with a combination of caudal epidural analgesia followed by Botox injection of perineal muscles. Indian J Urol 2014;30:350-3.
41. Vas L, Pai R, Khandagale N, Pattnaik M. Myofascial trigger points as a cause of abnormal cocontraction in writer's cramp. Pain Med 2015;16:2043-6.
42. Dommerholt J, Grieve R, Layton M, Hooks T. An evidence-informed review of the current myofascial pain literature-January 2015. J Bodyw Mov Ther 2015;19:126-37.
43. Chou LW, Kao MJ, Lin JG. Probable mechanisms of needling therapies for myofascial pain control. Evid Based Complement Alternat Med 2012;2012:705327.
44. Chen JT, Chung KC, Hou CR, Kuan TS, Chen SM, Hong CZ. Inhibitory effect of dry needling on the spontaneous electrical activity recorded from myofascial trigger spots of rabbit skeletal muscle. Am J Phys Med Rehabil 2001;80:729-35.
45. Srbely JZ, Dickey JP, Lee D, Lowerison M. Dry needle stimulation of myofascial trigger points evokes segmental anti-nociceptive effects. J Rehabil Med 2010;42:463-8.
46. Lewit K. The needle effect in the relief of myofascial pain. Pain 1979;6:83-90.
47. Woolf CJ, Mannion RJ. Neuropathic pain: Aetiology, symptoms, mechanisms, and management. Lancet 1999;353:1959-64.
48. Planjar-Prvan M, Bielen I, Baraba R, Buljan R. Pathophysiologic basis of the treatment of neurogenic pain. Acta Med Croatica 2004;58:197-205.